Form 4 Filing for Graf Susan E at CG Oncology, Inc.

This filing details a Form 4 submission by Graf Susan E, a director at CG Oncology, Inc. (CGON). On June 4, 2026, Susan Graf was granted a stock option to purchase 9,354 shares of common stock at an exercise price of $56.09 per share. The option has an expiration date of June 3, 2036. The vesting schedule indicates that 1/12th of the total shares subject to the option will vest monthly, starting from June 4, 2026, contingent upon her continued service to the company. In the event that the company's next annual stockholder meeting occurs before the first anniversary of the grant date, any unvested portion of the stock option will vest on the date of that meeting. Following this transaction, Graf Susan E directly owns 9,354 shares of common stock.